Exact Sciences (EXAS) News Today → [URGENT] DO NOT Touch These AI Stocks! (From Weiss Ratings) (Ad) Free EXAS Stock Alerts $50.38 -1.57 (-3.02%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 17 at 9:24 PM | marketbeat.comNikko Asset Management Americas Inc. Sells 204,394 Shares of Exact Sciences Co. (NASDAQ:EXAS)Nikko Asset Management Americas Inc. lowered its position in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 10.4% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 1,758,853 shares of the medical research company's stock after selling 204,394 shaMay 17 at 6:27 AM | investorplace.comWall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for May 2024May 16 at 6:51 PM | marketbeat.comExact Sciences (NASDAQ:EXAS) Reaches New 12-Month Low at $51.91Exact Sciences (NASDAQ:EXAS) Reaches New 12-Month Low at $51.91May 16 at 9:19 AM | markets.businessinsider.comCologuard’s Market Share Surge Powers Buy RatingMay 15, 2024 | marketbeat.comPrincipal Financial Group Inc. Has $65.54 Million Stock Position in Exact Sciences Co. (NASDAQ:EXAS)Principal Financial Group Inc. reduced its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 13.3% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 885,916 shares of the medical research company's stock afterMay 15, 2024 | americanbankingnews.comExact Sciences Co. (NASDAQ:EXAS) Short Interest Down 10.2% in AprilMay 15, 2024 | marketbeat.comShort Interest in Exact Sciences Co. (NASDAQ:EXAS) Drops By 10.2%Exact Sciences Co. (NASDAQ:EXAS - Get Free Report) was the target of a significant decrease in short interest during the month of April. As of April 30th, there was short interest totalling 8,880,000 shares, a decrease of 10.2% from the April 15th total of 9,890,000 shares. Based on an average trading volume of 2,490,000 shares, the days-to-cover ratio is currently 3.6 days.May 14, 2024 | marketbeat.comEmpire Life Investments Inc. Has $19.51 Million Stake in Exact Sciences Co. (NASDAQ:EXAS)Empire Life Investments Inc. grew its holdings in Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 18.5% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 263,689 shares of the medical research company's stock after purchasing an additionalMay 14, 2024 | marketbeat.comExact Sciences (NASDAQ:EXAS) Shares Down 3.7% Exact Sciences (NASDAQ:EXAS) Stock Price Down 3.7%May 13, 2024 | americanbankingnews.comBTIG Research Lowers Exact Sciences (NASDAQ:EXAS) Price Target to $80.00May 13, 2024 | americanbankingnews.comLeerink Partnrs Weighs in on Exact Sciences Co.'s Q2 2024 Earnings (NASDAQ:EXAS)May 12, 2024 | americanbankingnews.comLeerink Partnrs Equities Analysts Reduce Earnings Estimates for Exact Sciences Co. (NASDAQ:EXAS)May 11, 2024 | finance.yahoo.comExact Sciences Corporation (NASDAQ:EXAS) First-Quarter Results: Here's What Analysts Are Forecasting For This YearMay 10, 2024 | finance.yahoo.comExact Sciences Corp (EXAS) Q1 2024 Earnings: Revenue Growth Amidst Increased Net LossMay 10, 2024 | marketbeat.comQ4 2025 EPS Estimates for Exact Sciences Co. (NASDAQ:EXAS) Lowered by Leerink PartnrsExact Sciences Co. (NASDAQ:EXAS - Free Report) - Stock analysts at Leerink Partnrs cut their Q4 2025 earnings per share estimates for Exact Sciences in a research report issued to clients and investors on Thursday, May 9th. Leerink Partnrs analyst P. Souda now anticipates that the medical researcMay 10, 2024 | markets.businessinsider.comOptimistic Outlook for Exact Sciences: Overcoming Challenges with Growth Initiatives and New Product PotentialMay 10, 2024 | finance.yahoo.comExact Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsMay 10, 2024 | businesswire.comThe National Institute for Health and Care Excellence (NICE) Recommends Use of Exact Sciences' Oncotype DX® Test to Help Guide Chemotherapy Decisions for Node-positive Breast Cancer PatientsMay 9, 2024 | markets.businessinsider.comPiper Sandler Keeps Their Buy Rating on Exact Sciences (EXAS)May 9, 2024 | markets.businessinsider.comBuy Rating Affirmed for Exact Sciences on Strong Performance and Promising Growth InitiativesMay 9, 2024 | markets.businessinsider.comBuy Rating Reiterated for Exact Sciences on Strong Q1 Performance and Positive Financial OutlookMay 9, 2024 | finance.yahoo.comQ1 2024 Exact Sciences Corp Earnings CallMay 9, 2024 | finance.yahoo.comExact Sciences Stock, A Cathie Wood Darling, Tumbles On 'Overblown' Growth ConcernsMay 9, 2024 | finance.yahoo.comExact Sciences Corporation (NASDAQ:EXAS) Q1 2024 Earnings Call TranscriptMay 9, 2024 | marketbeat.comExact Sciences (NASDAQ:EXAS) Hits New 52-Week Low at $53.63Exact Sciences (NASDAQ:EXAS) Hits New 1-Year Low at $53.63May 9, 2024 | benzinga.comExact Sciences Reports Q1 Loss, Joins Beyond Meat, Duolingo And Other Big Stocks Moving Lower In Thursday's Pre-Market SessionMay 9, 2024 | finance.yahoo.comExact Sciences Corp (EXAS) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth ...May 9, 2024 | marketbeat.comLos Angeles Capital Management LLC Acquires New Position in Exact Sciences Co. (NASDAQ:EXAS)Los Angeles Capital Management LLC bought a new position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 18,142 shares of the medical research compaMay 9, 2024 | markets.businessinsider.comBuy Rating Affirmed for Exact Sciences Amidst Strong Growth and Innovative PipelineMay 9, 2024 | msn.comExact Sciences (EXAS) Q1 2024 Earnings Call TranscriptMay 8, 2024 | finance.yahoo.comExact Sciences Announces First-Quarter 2024 ResultsMay 8, 2024 | msn.comExact Sciences GAAP EPS of -$0.60 misses by $0.11, revenue of $637.52M beats by $10.71MMay 8, 2024 | msn.comExact Sciences Stock Plunges On Q1 Earnings: What You Need To KnowMay 8, 2024 | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Shares Sold by Swiss National BankSwiss National Bank trimmed its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 2.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 564,980 shares of the medical research company's stockMay 7, 2024 | finance.yahoo.comExact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW® 2024May 5, 2024 | marketbeat.comVictory Capital Management Inc. Has $55.50 Million Position in Exact Sciences Co. (NASDAQ:EXAS)Victory Capital Management Inc. increased its holdings in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 47.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 750,228 shares of the medical reseMay 4, 2024 | marketbeat.comVestmark Advisory Solutions Inc. Purchases Shares of 41,519 Exact Sciences Co. (NASDAQ:EXAS)Vestmark Advisory Solutions Inc. bought a new position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 41,519 shares of the medical research cMay 3, 2024 | insidertrades.comExact Sciences Co. (NASDAQ:EXAS) CEO Kevin T. Conroy Sells 1,155 SharesMay 3, 2024 | marketbeat.comInternational Assets Investment Management LLC Makes New Investment in Exact Sciences Co. (NASDAQ:EXAS)International Assets Investment Management LLC acquired a new stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 187,465 shares of the medical research company's stocMay 1, 2024 | businesswire.comExact Sciences to Participate in May Investor ConferenceApril 27, 2024 | marketbeat.comExact Sciences Co. (NASDAQ:EXAS) Sees Significant Increase in Short InterestExact Sciences Co. (NASDAQ:EXAS - Get Free Report) saw a significant increase in short interest in April. As of April 15th, there was short interest totalling 9,890,000 shares, an increase of 56.0% from the March 31st total of 6,340,000 shares. Based on an average daily trading volume, of 2,390,000 shares, the short-interest ratio is currently 4.1 days.April 27, 2024 | marketbeat.comNew York State Common Retirement Fund Reduces Stock Position in Exact Sciences Co. (NASDAQ:EXAS)New York State Common Retirement Fund lowered its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 5.6% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 320,607 shares of the medical research company's sApril 24, 2024 | finance.yahoo.comHere’s Why Baron Health Care Fund Reduced Exact Sciences Corporation (EXAS)April 23, 2024 | marketbeat.comJennison Associates LLC Has $100.68 Million Stake in Exact Sciences Co. (NASDAQ:EXAS)Jennison Associates LLC increased its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 94.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,360,917 shares of the medical research companyApril 21, 2024 | marketbeat.comArdevora Asset Management LLP Sells 59,792 Shares of Exact Sciences Co. (NASDAQ:EXAS)Ardevora Asset Management LLP lowered its position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) by 42.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 80,461 shares of the medical research cApril 20, 2024 | marketbeat.comGrandfield & Dodd LLC Acquires New Stake in Exact Sciences Co. (NASDAQ:EXAS)Grandfield & Dodd LLC acquired a new stake in Exact Sciences Co. (NASDAQ:EXAS - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 22,771 shares of the medical research company'sApril 17, 2024 | finance.yahoo.comExact Sciences Corporation's (NASDAQ:EXAS) Profit OutlookApril 16, 2024 | marketbeat.comHealthInvest Partners AB Takes $899,000 Position in Exact Sciences Co. (NASDAQ:EXAS)HealthInvest Partners AB acquired a new position in shares of Exact Sciences Co. (NASDAQ:EXAS - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 12,157 shares of the medical research company's stock, valued at approximately $899,000. OApril 16, 2024 | marketbeat.comStock Traders Purchase Large Volume of Call Options on Exact Sciences (NASDAQ:EXAS)Exact Sciences Co. (NASDAQ:EXAS - Get Free Report) saw unusually large options trading activity on Tuesday. Stock traders bought 16,937 call options on the stock. This is an increase of 291% compared to the average daily volume of 4,328 call options.April 15, 2024 | markets.businessinsider.comExact Sciences Appoints Aaron Bloomer As Chief Financial Officer Get Exact Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EXAS and its competitors with MarketBeat's FREE daily newsletter. Email Address Man who spotted Apple at $1.49 says: “Buy These 6 AI Stocks.” (Ad)Man who spotted Apple at $1.49 says: "Buy These 6 AI Stocks." And these will be the biggest winners EXAS Media Mentions By Week EXAS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. EXAS News Sentiment▼0.340.42▲Average Medical News Sentiment EXAS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. EXAS Articles This Week▼147▲EXAS Articles Average Week Get Exact Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for EXAS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Natera News Quest Diagnostics News Exelixis News Laboratory Co. of America News RadNet News Fortrea News Solventum News Universal Health Services News Smith & Nephew News Fresenius Medical Care News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:EXAS) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society41 banks launch ‘crypto dollar’Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exact Sciences Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
